Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Ågren

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|January 7, 2018
Point mutation of a conserved aspartate, D69, in the muscarinic M<sub>2</sub> receptor does not modify voltage-sensitive agonist potencyRichard Ågren, Kristoffer Sahlholm, Johanna Nilsson, et al.
Toxics|December 22, 2023
Neuropathy with Cerebral Features Induced by Nitrous Oxide Abuse-A Case ReportErik Lindeman, Sara Melin, Martin Paucar, et al.
Stereotactic and Functional Neurosurgery|July 16, 2020
Pulse Width and Implantable Pulse Generator Longevity in Pallidal Deep Brain Stimulation for Dystonia: A Population-Based Comparative Effectiveness StudyRichard Ågren, Jiri Bartek, Anders Johansson, et al.
Current Opinion in Virology|March 1, 2026
Ancestral FUT2 genetic adaptation confers resistance to modern norovirus and rotavirus infectionsJohan Nordgren, Richard Ågren, Marie Hagbom, et al.
Science Signaling|December 2, 2025
<i>GNAI1</i> missense mutations associated with a neurodevelopmental syndrome modify Gα<sub>i1</sub> functionMarlene Fritsche, Gaia Picozzi, Tomas Nyman, et al.
International Journal of Molecular Sciences|April 30, 2021
Dopamine D<sub>2</sub> Receptor Agonist Binding Kinetics-Role of a Conserved Serine ResidueRichard Ågren, Tomasz Maciej Stepniewski, Hugo Zeberg, et al.
The International Journal of Neuropsychopharmacology|August 7, 2023
In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate AntipsychoticsRichard Ågren, Nibal Betari, Marcus Saarinen, et al.
Molecular Biology and Evolution|June 14, 2023
Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From NeandertalsRichard Ågren, Snehal Patil, Xiang Zhou, et al.
International Journal of Molecular Sciences|July 14, 2023
An E280K Missense Variant in <i>KCND3</i>/Kv4.3-Case Report and Functional CharacterizationRichard Ågren, Niels Geerdink, Han G Brunner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2022
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT<sub>1A</sub> receptor agonist SEP-383856Marcus Saarinen, Ioannis Mantas, Ivana Flais, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|January 7, 2018
Point mutation of a conserved aspartate, D69, in the muscarinic M<sub>2</sub> receptor does not modify voltage-sensitive agonist potencyRichard Ågren, Kristoffer Sahlholm, Johanna Nilsson, et al.
Toxics|December 22, 2023
Neuropathy with Cerebral Features Induced by Nitrous Oxide Abuse-A Case ReportErik Lindeman, Sara Melin, Martin Paucar, et al.
Stereotactic and Functional Neurosurgery|July 16, 2020
Pulse Width and Implantable Pulse Generator Longevity in Pallidal Deep Brain Stimulation for Dystonia: A Population-Based Comparative Effectiveness StudyRichard Ågren, Jiri Bartek, Anders Johansson, et al.
Current Opinion in Virology|March 1, 2026
Ancestral FUT2 genetic adaptation confers resistance to modern norovirus and rotavirus infectionsJohan Nordgren, Richard Ågren, Marie Hagbom, et al.
Science Signaling|December 2, 2025
<i>GNAI1</i> missense mutations associated with a neurodevelopmental syndrome modify Gα<sub>i1</sub> functionMarlene Fritsche, Gaia Picozzi, Tomas Nyman, et al.
International Journal of Molecular Sciences|April 30, 2021
Dopamine D<sub>2</sub> Receptor Agonist Binding Kinetics-Role of a Conserved Serine ResidueRichard Ågren, Tomasz Maciej Stepniewski, Hugo Zeberg, et al.
The International Journal of Neuropsychopharmacology|August 7, 2023
In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate AntipsychoticsRichard Ågren, Nibal Betari, Marcus Saarinen, et al.
Molecular Biology and Evolution|June 14, 2023
Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From NeandertalsRichard Ågren, Snehal Patil, Xiang Zhou, et al.
International Journal of Molecular Sciences|July 14, 2023
An E280K Missense Variant in <i>KCND3</i>/Kv4.3-Case Report and Functional CharacterizationRichard Ågren, Niels Geerdink, Han G Brunner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2022
TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT<sub>1A</sub> receptor agonist SEP-383856Marcus Saarinen, Ioannis Mantas, Ivana Flais, et al.
Pageof 4